DSGN - Balance Sheet - Design Therapeutics, Inc.

Current Liabilities	8.46 M
Accounts Payable	2.19 M
Short-Term Debt	0
Other Current Liabilities	6.28 M
Non-Current Liabilities	1.53 M
Long-Term Debt	0
Other Non-Current Liabilities	1.53 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	22.6	21.2	26.5	298.6	2.4	77 K
Short Term Investments	222.9	260.6	303.9	85.5	33.7	0
Receivables	0	1.4	1.1	0.1	10 K	0
Inventory	0	0	(1.1)	1.3	0.1	0
Other Current Assets	0	1.4	8.3	1.3	0.1	5 K
Total Current Assets	248.0	284.6	335.1	385.4	36.2	90 K
PP&E	3.6	4.6	5.6	5.1	71 K	0
Intangible Assets	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	0.4	0.4	0.5	0	0.2	0
Other Assets	0	0	0	0	0	0
Total Assets	252.1	289.6	341.1	390.6	36.5	90 K
LIABILITIES
Accounts Payable	2.2	1.9	3.0	1.6	1.4	2.5
Short Term Debt	0	0.7	0.6	0.5	0	0.7
Other Current Liabilities	6.3	7.0	7.1	3.2	0.9	0.4
Total Current Liabilities	8.5	9.6	10.8	5.3	2.3	3.7
Long Term Debt	0	2.3	6.1	6.3	0	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	0	0	(3.1)	(3.1)	45.5	1 K
Total Liabilities	10.0	12.0	13.8	8.4	47.8	3.7
EQUITY
Common Stock	6 K	6 K	6 K	6 K	1 K	1 K
Retained Earnings	(227.2)	(177.6)	(110.8)	(47.5)	(11.9)	(3.6)
Other Accumulative Comprehensive Income/Loss	0.5	62 K	(3.4)	(0.2)	0.2	0
Total Equity	242.1	277.7	327.3	382.1	(11.3)	(3.6)
Total Liabilities and Equity	252.1	289.6	341.1	390.6	36.5	90 K
SHARES OUTSTANDING
Common Shares Outstanding	56.6	56.0	55.7	45.9	27.2	27.2

Free